The relative rapidity of recanalization induced by recombinant tissue-type plasminogen activator (r-tPA) and TNK-tPA, assessed with enzymatic methods

Coronary Artery Disease

Volumn 11, Issue 5, 2000, Pages 429-435

  Binbrek, Azan ^a   Rao, Nayan ^a   Absher, P Marlene ^b   Van De Werf, Frans ^c   Sobel, Burton E ^b,d  

^a RASHID HOSPITAL   (United Arab Emirates)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d University of Vermont Colchester Research Facility   (United States)

Author keywords

Creatine kinase isoforms; Fibrinolysis; Myocardial infarction; Plasminogen activators

Indexed keywords

ALTEPLASE; ARGININE CARBOXYPEPTIDASE; CREATINE KINASE; CREATINE KINASE MB; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ARTICLE; BLOOD CLOT LYSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; TIME;

BIOLOGICAL MARKERS; CREATINE KINASE; CREATINE KINASE, MM FORM; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; HUMANS; ISOENZYMES; MYOCARDIAL INFARCTION; PLASMINOGEN ACTIVATORS; RECOMBINANT PROTEINS; SAFETY; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 0033917973     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200007000-00008     Document Type: Article

References (27)

1. 1 The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329:673-682.
2. 2 Simes RJ, Topol EJ, Holmes DR Jr, White HD, Rutsch WR, Vahanian A, et al. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. Circulation 1995; 91:1923-1928.
3. 3 Bergmann SR, Fox KAA, Ter-Pogossian MM, Sobel BE, Collen D. Clot-selective coronary thrombolysis with tissue-type plasminogen activator. Science 1983; 220:1181-1183.
4. 4 Van de Werf F, Ludbrook PA, Bergmann SR, Tiefenbrunn AJ, Fox KAA, de Geest H, et al. Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction. N Engl J Med 1984; 310:609-613.
5. 5 TIMI Study Group. Special report. The thrombolysis in myocardial infarction (TIMI) trial. N Engl J Med 1985; 32:932-936.
6. 6 Eisenberg PR, Miletich JP, Sobel BE. Factors responsible for differential procoagulant effects of diverse plasminogen activators in plasma. Fibrinolysis 1991; 5:217-224.
7. 7 Eisenberg PR, Sobel BE, Jaffe AS. Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol 1992; 19:1065-1069.
8. 8 Sobel BE, Nachowiak DA, Fry ETA, Bergmann SR, Torr SR. Paradoxical attenuation of fibrinolysis attributable to 'plasminogen steal' and its implications for coronary thrombolysis. Coron Artery Dis 1990; 1:111-119.
9. 9 Torr SR, Nachowiak DA, Fujii S, Sobel BE. 'Plasminogen steal' and clot lysis. J Am Coll Cardiol 1992; 19:1085-1090.
10. 10 Plow EF, Felez J, Miles LA. Cellular regulation of fibrinolysis. Thromb Haemost 1991; 66:32-36.
11. 11 Bates SM, Weitz JI. The new heparins. Coron Artery Dis 1998; 9:65-74.
12. 12 Gardell SJ, Sanderson PEJ. Novel anticoagulants based on direct inhibition of thrombin and factor Xa. Coron Artery Dis 1998; 9:75-81.
13. 13 Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 17 trial. The TIMI 14 Investigators. Circulation 1999; 99:2720-2732.
14. 14 Vanderschueren S, Barrios L, Kerdsinchai P, Van den Heuvel P, Hermans L, Vrolix M, et al. A randomized trial of recombinant staphylokinase versus alteplase for coronary artery patency in acute myocardial infarction. Circulation 1995; 92:2044-2049.
15. 15 Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenacteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomized trial. Lancet 1999; 354:716-722.
16. 16 Califf RM. Issues in thrombolysis: insights from the GUSTO trials of studies of coronary reperfusion. In: Nash IS, Fuster V (editors). Efficacy of myocardial infarction therapy. New York: Marcel Dekker, Inc.; 1999. pp. 73-86.
17. 17 Fry ETA, Sobel BE. Coronary thrombolysis. In: Zipes DP, Rowlands DJ (editors). Progress in Cardiology. Philadelphia: Lea & Febiger; 1990. pp. 199-239.
18. 18 Scharfstein JS, Abendschein DR, Eisenberg PR, George D, Cannon CP, Becker RC, et al. Usefulness of fibrinogenolytic and procoagulant markers during thrombolytic therapy in predicting clinical outcomes in acute myocardial infarction. Am J Cardiol 1996; 78:503-510.
19. 19 Seacord LM, Abendschein DR, Nohara R, Hartzler G, Sobel BE, Jaffe AS. Detection of reperfusion within 1 hour after coronary recanalization by analysis of isoforms of the MM creatine kinase isoenzyme in plasma. Fibrinolysis 1988; 2:151-156.
20. 20 Abendschein DR, Serota H, Plummer TH Jr, Amiraian D, Strauss AW, Sobel BE, et al. Conversion of MM creatine kinase isoforms in human plasma by carboxypeptidase N. J Lab Clin Med 1987; 110:798-806.
21. 21 Laperche T, Steg G, Dehoux M, Benessiano J, Grollier G, Aliot E, et al. A study of biochemical markers of reperfusion early after thrombolysis for acute myocardial infarction. Circulation 1995; 92:2079-2086.
22. 22 Clark GL, Robison AK, Gnepp DR, Roberts R, Sobel BE. Effects of lymphatic transport of enzyme on plasma creatine kinase time-activity curves after myocardial infarction in dogs. Circ Res 1978; 43:162-169.
23. 23 Hashimoto H, Abendschein DR, Sobel BE. Early detection of myocardial infarction in conscious dogs by analysis of plasma MM creatine kinase isoforms. Circulation 1985; 71:363-369.
24. 24 Devries SR, Sobel BE, Abendschein DR. Early detection of myocardial reperfusion by assay of plasma MM creatine kinase isoforms in dogs. Circulation 1986; 74:567-572.
25. 25 Abendschein DR, Ellis AK, Eisenberg PR, Klocke FJ, Sobel BE, Jaffe AS. Prompt detection of coronary recanalization by analysis of rates of change of concentrations of macromolecular markers in plasma. Coron Artery Dis 1991; 2:201-212.
26. 26 Kjekshus JK, Sobel BE. Depressed myocardial creatine phosphokinase activity following experimental myocardial infarction in rabbit. Circ Res 1970; 27:403-414.
27. 27 Sobel BE, Furberg CD. Surrogates, semantics, and sensible public policy. Special commentary. Circulation 1997; 94:1661-1663.